Porceddu SV - Search Results

1

The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.

Pryor DI, Solomon B, Porceddu SV. Pryor DI, et al. Among authors: porceddu sv. Asia Pac J Clin Oncol. 2011 Sep;7(3):236-51. doi: 10.1111/j.1743-7563.2011.01420.x. Asia Pac J Clin Oncol. 2011. PMID: 21884435 Review.

2

Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.

Porceddu SV, Campbell B, Rischin D, Corry J, Weih L, Guerrieri M, Grossi M, Peters LJ. Porceddu SV, et al. Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):365-73. doi: 10.1016/j.ijrobp.2004.03.011. Int J Radiat Oncol Biol Phys. 2004. PMID: 15380568

3

Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck.

Ware RE, Matthews JP, Hicks RJ, Porceddu S, Hogg A, Rischin D, Corry J, Peters LJ. Ware RE, et al. Head Neck. 2004 Dec;26(12):1008-17. doi: 10.1002/hed.20097. Head Neck. 2004. PMID: 15459925

4

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.

Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, Peters LJ; Trans-Tasman Radiation Oncology Group Study 98.02. Rischin D, et al. J Clin Oncol. 2006 May 1;24(13):2098-104. doi: 10.1200/JCO.2005.05.2878. J Clin Oncol. 2006. PMID: 16648512 Clinical Trial.

5

Head and neck cancer: past, present and future.

Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Chin D, et al. Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8. doi: 10.1586/14737140.6.7.1111. Expert Rev Anticancer Ther. 2006. PMID: 16831082 Review.

6

Locally advanced tonsillar squamous cell carcinoma: Treatment approach revisited.

Poulsen M, Porceddu SV, Kingsley PA, Tripcony L, Coman W. Poulsen M, et al. Among authors: porceddu sv. Laryngoscope. 2007 Jan;117(1):45-50. doi: 10.1097/01.mlg.0000243044.91193.32. Laryngoscope. 2007. PMID: 17202929

7

Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes.

Veness MJ, Porceddu S, Palme CE, Morgan GJ. Veness MJ, et al. Head Neck. 2007 Jul;29(7):621-31. doi: 10.1002/hed.20576. Head Neck. 2007. PMID: 17230560 Review.

8

Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".

Porceddu SV, Rosser B, Burmeister BH, Jones M, Hickey B, Baumann K, Gogna K, Pullar A, Poulsen M, Holt T. Porceddu SV, et al. Radiother Oncol. 2007 Dec;85(3):456-62. doi: 10.1016/j.radonc.2007.10.020. Epub 2007 Nov 26. Radiother Oncol. 2007. PMID: 18036689

9

Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone.

Poulsen MG, Riddle B, Keller J, Porceddu SV, Tripcony L. Poulsen MG, et al. Among authors: porceddu sv. Radiother Oncol. 2008 May;87(2):253-9. doi: 10.1016/j.radonc.2008.03.010. Epub 2008 Apr 12. Radiother Oncol. 2008. PMID: 18410976

10

Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.

Pryor DI, Porceddu SV, Burmeister BH, Guminski A, Thomson DB, Shepherdson K, Poulsen M. Pryor DI, et al. Among authors: porceddu sv. Radiother Oncol. 2009 Feb;90(2):172-6. doi: 10.1016/j.radonc.2008.09.018. Epub 2008 Oct 29. Radiother Oncol. 2009. PMID: 18976827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters